⌘K

Login Start Free

Home/Insiders/Partridge Andrew John

PA

SEC Insider//CIK 0001758838

Partridge Andrew John

CIK 00017588381 companySAN DIEGO, CA

Transactions

8

Companies

1

Filings

4

CIK

0001758838

Recent Transactions

8 trades

Sale
Turning Point Therapeutics, Inc.
Common Stock
2022-02-09$36.30/sh−221→ 22,078 total
Award
Turning Point Therapeutics, Inc.
Common Stock
2022-02-09+16,283→ 38,361 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-02-09+58,600→ 58,600 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-07-14$74.90/sh−1,869→ 21,767 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-02-08+9,733→ 9,733 total
Award
Turning Point Therapeutics, Inc.
Common Stock
2021-02-08+2,136→ 23,636 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2020-07-13+127,500→ 127,500 total
Award
Turning Point Therapeutics, Inc.
Common Stock
2020-07-13+21,500→ 21,500 total

Companies

1

Turning Point Therapeutics, Inc.
EVP & Chief Commercial Officer

Recent Filings

4

Address

C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov